Literature DB >> 33585470

Fas-Activated Serine/Threonine Kinase Governs Cardiac Mitochondrial Complex I Functional Integrity in Ischemia/Reperfusion Heart.

Xiyao Chen1, Guangyu Hu2, Yuanyuan Wang3, Congye Li2, Fuyang Zhang2,4.   

Abstract

Cardiac energy homeostasis is strictly controlled by the mitochondrial complex-mediated respiration. In the heart, mitochondrial complex I is highly susceptible to functional and structural destroy after ischemia/reperfusion (I/R), thereby contributing to myocardial energy insufficiency and cardiomyocyte death. Fas-activated serine/threonine kinase (FASTK) is recently recognized as a key modulator of mitochondrial gene expression and respiration. However, the role of FASTK in cardiac I/R process is undetermined. Here, we show that FASTK expression was down-regulated in the post-I/R heart. The reactive oxygen species scavenger N-acetyl-L-cysteine reversed I/R-induced FASTK down-regulation. Genetic deletion of FASTK exacerbated I/R-induced cardiac dysfunction, enlarged myocardial infarct size, and increased cardiomyocyte apoptosis. Compared with the wild type control, the FASTK deficient heart exhibited a lower mRNA expression of NADH dehydrogenase subunit-6 (MTND6, a mitochondrial gene encoding a subunit of complex I) and was more vulnerable to I/R-associated complex I inactivation. Replenishment of FASTK expression via adenovirus-mediated gene delivery restored mitochondrial complex I activity and ameliorated cardiomyocyte death induced by I/R, whereas these beneficial effects were blocked by the co-treatment with rotenone, a specific complex I inhibitor. in vivo experiments further confirmed that cardiac overexpression of FASTK ameliorated I/R-related MTND6 down-regulation and mitochondrial complex I inactivation, thereby protecting the heart against I/R injury. Collectively, these data for the first time identify that the down-regulation of FASTK is a direct culprit behind the loss of mitochondrial complex I functional integrity and cardiac injury induced by I/R process. Targeting FASTK might be a promising and effective strategy for MI/R intervention.
Copyright © 2021 Chen, Hu, Wang, Li and Zhang.

Entities:  

Keywords:  FASTK; MTND6; complex I; ischemia/reperfusion; mitochondrion

Year:  2021        PMID: 33585470      PMCID: PMC7876271          DOI: 10.3389/fcell.2020.630421

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN: 2296-634X


  25 in total

Review 1.  The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge.

Authors:  Gerd Heusch; Bernard J Gersh
Journal:  Eur Heart J       Date:  2017-03-14       Impact factor: 29.983

2.  Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure.

Authors:  Rob C I Wüst; Heder J de Vries; Liesbeth T Wintjes; Richard J Rodenburg; Hans W M Niessen; Ger J M Stienen
Journal:  Cardiovasc Res       Date:  2016-07-11       Impact factor: 10.787

Review 3.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

4.  Mitochondria in Ischemic Heart Disease.

Authors:  L Maximilian Buja
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  A mitochondria-specific isoform of FASTK is present in mitochondrial RNA granules and regulates gene expression and function.

Authors:  Alexis A Jourdain; Mirko Koppen; Christopher D Rodley; Kinsey Maundrell; Naïg Gueguen; Pascal Reynier; Adela M Guaras; José A Enriquez; Paul Anderson; Maria Simarro; Jean-Claude Martinou
Journal:  Cell Rep       Date:  2015-02-19       Impact factor: 9.423

Review 6.  Reducing the Global Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors.

Authors:  Philip Joseph; Darryl Leong; Martin McKee; Sonia S Anand; Jon-David Schwalm; Koon Teo; Andrew Mente; Salim Yusuf
Journal:  Circ Res       Date:  2017-09-01       Impact factor: 17.367

7.  Mitochondrial Complex I Dysfunction and Peripheral Chemoreflex Sensitivity in a FASTK-Deficient Mice Model.

Authors:  Angela Gomez-Niño; Inmaculada Docio; Jesus Prieto-Lloret; Maria Simarro; Miguel A de la Fuente; Asuncion Rocher
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 8.  Acute myocardial infarction.

Authors:  Grant W Reed; Jeffrey E Rossi; Christopher P Cannon
Journal:  Lancet       Date:  2016-08-05       Impact factor: 79.321

Review 9.  The FASTK family of proteins: emerging regulators of mitochondrial RNA biology.

Authors:  Alexis A Jourdain; Johannes Popow; Miguel A de la Fuente; Jean-Claude Martinou; Paul Anderson; Maria Simarro
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

10.  NDUFAB1 confers cardio-protection by enhancing mitochondrial bioenergetics through coordination of respiratory complex and supercomplex assembly.

Authors:  Tingting Hou; Rufeng Zhang; Chongshu Jian; Wanqiu Ding; Yanru Wang; Shukuan Ling; Qi Ma; Xinli Hu; Heping Cheng; Xianhua Wang
Journal:  Cell Res       Date:  2019-07-31       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.